Effects of endogenous interleukin 1 on blast cells derived from acute myelogenous leukemia patients
Author:
- 1 January 1996
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 20 (1) , 65-73
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Cytokine modulation of interleukin 1 and tumour necrosis factor-α secretion from acute myelogenous leukaemia blast cells in vitroLeukemia Research, 1995
- Hematologic and immunomodulatory effects of an interleukin-1 receptor antagonist coinfusion during low-dose endotoxemia in healthy humansBlood, 1993
- Effects of dipyridamole and R-verapamil on in vitro proliferation of blast cells from patients with acute myelogenous leukaemiaLeukemia Research, 1993
- Effect of Dipyridamole, Theophyllamine and Verapamil on Spontaneous in Vitro Proliferation of Myelogenous Leukaemia CellsActa Oncologica, 1992
- Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cellsBlood, 1991
- Interleukin-1 and interleukin-1 antagonismBlood, 1991
- Differential binding of IL‐ 1α and IL‐ 1β to receptors on B and T cellsFEBS Letters, 1989
- Growth of clonogenic myeloblastic leukemic cells in the presence of human recombinant erythropoietin in addition to various human recombinant hematopoietic growth factorsBlood, 1988
- Allogeneic bone marrow transplantation for acute nonlymphocytic leukemia in first remissionBlood, 1988
- Autocrine stimulation of interleukin 1 beta in acute myelogenous leukemia cells.Journal of Experimental Medicine, 1987